Insider · CIK 0001341752
Eileen K Murray
director
Files at BR (BROADRIDGE FINANCIAL SOLUTIONS, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Common Stock | +20 | $0.00 | $0 | 6,167 | 5 d ago |
| Oct 5, 2026 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Common Stock | +18 | $0.00 | $0 | 6,185 | 5 d ago |
| Sep 24, 2026 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Common Stock | +389 | $0.00 | $0 | 6,147 | 13 d ago |
| Mar 19, 2025 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Common Stock | +181 | $0.00 | $0 | 3,329 | Mar 20, 2025 |
| Jan 3, 2025 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Common Stock | +6 | $0.00 | $0 | 3,144 | Jan 10, 2025 |
| Jan 3, 2025 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Common Stock | +4 | $0.00 | $0 | 3,148 | Jan 10, 2025 |
| Dec 16, 2024 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Common Stock | +188 | $0.00 | $0 | 3,138 | Dec 17, 2024 |
| Nov 14, 2024 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Common Stock | +613 | $0.00 | $0 | 2,950 | Nov 15, 2024 |
| Nov 14, 2024 | BR BROADRIDGE FINANCIAL SOLUTIONS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +2,467 | $0.00 | $0 | 2,467 | Nov 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.